News
-
Better understanding of cancer drugs – Leiden spin-off Omivera receives seed investmentImpact 12 February 2026How do you know if a drug will actually work? The Leiden-based spin-off Omivera is developing a new technology that could provide clearer answers. The...
-
How Leiden University is taking action against cancerWorld Cancer Day 04 February 2026One in two people will be diagnosed with cancer. World Cancer Day on 4 February raises awareness of the impact of this devastating disease. Leiden Uni...
-
A faster way to find new medicines – without the limitations of big DNA barcodesDRUG DISCOVERY 30 October 2025Leiden researchers, led by Sebastian Pomplun developed a new method to screen hundreds of thousands of molecules for drug discovery, using mass spectr...
-
‘Never stop trying’: Barz sees his polymers enter clinical trialsDrug discovery 11 September 2025A new class of polymers has been used in patients for the first time. The compound is the first new drug solubilising agent in decades. Introduced in...
-
A future with tailored therapy for patients with atherosclerosisGrant awarded 11 September 2025Personalised treatment for patients with atherosclerosis. That is what the researchers of the AtheroNeth consortium are working towards. The Dutch Hea...
-
European Proof of Concept grants for two Leiden researchers14 July 2025Two Leiden researchers have been awarded ERC Proof of Concept grants. These grants, each worth EUR 150,000, will help the grantees in their efforts to...
-
Leiden-developed drug candidate ready for final clinical trial phaseImpact 27 May 2025Bringing your drug candidates to patients is what many academic chemists dream about, but the road to this goal is long and bumpy. Now, Leiden small m...
-
These were Leiden University’s interdisciplinary milestones of 202417 December 2024Connecting scientific fields, enhancing research and teaching, and providing innovative solutions to complex social issues: that is the idea behind in...
-
Antibodies against rheumatic diseases tested directly on patients20 November 2024Leiden Professor of Translational Rheumatology Hans Ulrich Scherer has one foot in the clinic, where he helps patients, and the other in the lab, wher...
-
RARE-NL: LUMC joins consortium to find treatments for rare diseases26 August 2024RARE-NL, a new collaboration between university hospitals, hopes to find treatments for rare diseases. Professor Teun van Gelder is representing the L...
-
Education that connects to market needs: new course for master’s students focuses on quality in drug development09 October 2023Immediately connect with the needs of industry with your master’s degree. The new course Practical Aspects of Quality Management in Pharma and Biotech...
-
The molecular secrets of medicinal cannabis23 March 2023Chronic pain, nausea or vomiting due to chemotherapy. If you suffer from such ailments, medicinal cannabis can be a godsend. Though a downside is that...
-
Madouc Bergers made her own enzyme inhibitors for her bachelor’s thesis06 January 2023For her bachelor’s thesis, Molecular Science and Technology student Madouc Bergers synthesized her own molecule that can inhibit the breakdown of suga...
-
From discovery to business: 'In the lab, we often don't realise that we are working to help an immense number of patients'06 October 2022'It gave our team a big boost to hear that our work was valuable,' says medical chemist Elmer Maurits about the moment they won the Venture Challenge....
-
Small molecule prevents tumour cells from spreading27 July 2022Leiden chemists, together with colleagues at the University of York (UK) and Technion (Israel) have discovered a small, sugar-like molecule that maint...